Science & Enterprise subscription

Please share Science & Enterprise

RSS
Follow by Email
Facebook
Facebook
Google+
Twitter
Visit Us
LinkedIn

Donate to our blog

Your support will help Science & Enterprise continue to provide science news for business people and business news for scientists.

Cancer Drug Shown to Improve Survival Time in Dogs

A drug to treat a deadly cancer in dogs was shown in a clinical trial to extend the survival time of canine patients by 6 months or more, with potential applications in humans. . . . → Read More: Cancer Drug Shown to Improve Survival Time in Dogs

Trial Planned to Evaluate CTE Blood Test

A clinical trial is planned of a blood test to detect an indicator of chronic traumatic encephalopathy. or CTE. a neurodegenerative disease associated with collision sports. . . . → Read More: Trial Planned to Evaluate CTE Blood Test

Trial to Test Liquid Biopsy for Breast Cancer Complication

A clinical trial plans to assess the use of a blood test to diagnose neurological complications from the spread of breast cancer. . . . → Read More: Trial to Test Liquid Biopsy for Breast Cancer Complication

Liquid Biopsy Better Detects Lung Cancer Mutations

Tests of blood and urine from patients with a common form of lung cancer show these liquid biopsies more accurately identified cancer-causing mutations than traditional tissue sample biopsies. . . . → Read More: Liquid Biopsy Better Detects Lung Cancer Mutations

Patent Awarded for Cancer-Fighting Antibody

A synthetic engineered antibody developed by MabVax Therapeutics that binds to solid tumor cells for cancer diagnostics and treatment received a U.S. patent. . . . → Read More: Patent Awarded for Cancer-Fighting Antibody

Mobile Multichannel Biomarker Detector Designed

An engineering lab designed a portable testing device connected to a smartphone that can analyze multiple specimen samples for a leading cancer biomarker. . . . → Read More: Mobile Multichannel Biomarker Detector Designed

Precision Medicine Shown to Boost Cancer Outcomes

(National Heart, Lung, and Blood Institute)

7 June 2016. An analysis of results from early-stage clinical trials shows trials using treatments for cancer aimed at specific molecular targets had higher response rates and longer survival times than studies not using these targets. The team from University of California in San Diego, led by postdoctoral . . . → Read More: Precision Medicine Shown to Boost Cancer Outcomes

Blood Test Guides Depression Drug Decisions

(AllanAjifo, Wikimedia Commons)

7 June 2016. A blood test for two key biomarkers can identify drugs for depression that match an individual’s condition with the disease, thus improving chances of success. A team from the lab of psychological medicine professor Carmine Pariante at Kings College London published its findings yesterday in the International Journal . . . → Read More: Blood Test Guides Depression Drug Decisions

Sensor Patch Tracks Chemical, Physical Vital Signs

Chem-Phys patch demonstrated by co-author Amay Bandodkar (University of California, San Diego)

24 May 2016. Engineers at University of California in San Diego developed a patch device worn on the skin with sensors that measure chemical indicators as well as physical vital signs. The UC-San Diego team that designed the device published its findings . . . → Read More: Sensor Patch Tracks Chemical, Physical Vital Signs

Venture Firm Funding Univ. Blood Diagnostics Technology

(Public Domain Pictures/Pixabay)

23 May 2016. A life sciences venture capital company is funding development of a technology at an Israeli research lab using DNA from blood tests to diagnose a range of diseases. Aurum Ventures is providing $1.2 million to Hebrew University of Jerusalem, through its technology transfer affiliate Yissum Research Development Company, . . . → Read More: Venture Firm Funding Univ. Blood Diagnostics Technology